Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 1/20 | 0.33 |
| ▸ | CNR2 | P34972 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17374776 | 0.87 | SMN1; SMN2 (0.33) | GAASMN1; SMN2ALDH1A1 | |
| SCHEMBL631669 | 0.86 | CNR1 (0.37) | CNR1CNR2GAASMN1; SMN2CYP1A2 | |
| SCHEMBL3550577 | 0.79 | CACNA1F (0.32) | GAASMN1; SMN2 | |
| SCHEMBL7781942 | 0.76 | HSP90AA1 (0.40) | GAASMN1; SMN2CYP2C19ALDH1A1 | |
| SCHEMBL647668 | 0.75 | HSP90AA1 (0.38) | CNR1CNR2GAASMN1; SMN2CYP1A2 | |
| SCHEMBL2076194 | 0.75 | ALDH1A1 (0.38) | CNR1CNR2GAASMN1; SMN2CYP1A2 | |
| SCHEMBL13439637 | 0.73 | CYP3A4 (0.41) | CNR1CNR2GAACYP1A2CYP2C19 | |
| SCHEMBL13548757 | 0.72 | AR (0.48) | GAASMN1; SMN2ALDH1A1 | |
| SCHEMBL4802713 | 0.70 | HSP90AA1 (0.42) | SMN1; SMN2CYP2C19ALDH1A1 | |
| SCHEMBL3550576 | 0.70 | SMN1; SMN2 (0.34) | GAASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210198180-A1 | PROCESS FOR PRODUCING SUBSTITUTED 4-AMINOINDANE DERIVATIVES FROM 2-(HYDROXYALKYL)-ANILINES | BAYER AG (DE) | 2021-07-01 | — | — | US | disclosed |
| US-20210198180-A1 | PROCESS FOR PRODUCING SUBSTITUTED 4-AMINOINDANE DERIVATIVES FROM 2-(HYDROXYALKYL)-ANILINES | BAYER AG (DE) | 2021-07-01 | — | — | US | disclosed |
| CN-112088154-A | Process for preparing substituted 4-aminoindan derivatives from 2- (hydroxyalkyl) -anilines | 拜耳公司 | 2020-12-15 | — | — | CN | disclosed |
| US-20190039995-A1 | METHOD FOR PREPARING SUBSTITUTED 4-AMINOINDANE DERIVATIVES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2019-02-07 | — | — | US | disclosed |
| US-20190039995-A1 | METHOD FOR PREPARING SUBSTITUTED 4-AMINOINDANE DERIVATIVES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2019-02-07 | — | — | US | disclosed |
| EP-3411354-A1 | METHOD FOR PRODUCING SUBSTITUTED 4-AMINOINDANE DERIVATIVES | Bayer CropScience Aktiengesellschaft (DE) | 2018-12-12 | — | — | EP | disclosed |
| WO-2017133981-A1 | METHOD FOR PRODUCING SUBSTITUTED 4-AMINOINDANE DERIVATIVES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2017-08-10 | — | — | WO | disclosed |
| WO-2017133981-A1 | METHOD FOR PRODUCING SUBSTITUTED 4-AMINOINDANE DERIVATIVES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2017-08-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210198180-A1 | PROCESS FOR PRODUCING SUBSTITUTED 4-AMINOINDANE DERIVATIVES FROM 2-(HYDROXYALKYL)-ANILINES | HTR3C, HTR4, HRH4 | CNR1 796/4885CNR2 280/4885GAA 3674/4885 |
| US-20190039995-A1 | METHOD FOR PREPARING SUBSTITUTED 4-AMINOINDANE DERIVATIVES | NQO2, CCND2, CYP4F2 | CNR1 885/4885CNR2 714/4885GAA 4629/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.